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Abstract 
GSK-3, a well-known serine/threonine kinase is one of the key players controlling 
numerous cellular and physiological processes such as protein synthesis, cell 
poliferation, cellular differentiation, apoptosis and microtubule dynamics. Therefore, 
GSK-3 phosphorylates and regulates the functions of a diverse group of substrates 
including many transcription factors, components regulating the cell cycles and 
signaling proteins. However, the mechanisms by which GSK-3 regulates the functions of 
many substrates specifically and selectively are not known. In order to understand the 
molecular basis of GSK-3 regulation and specificity, we attempt to search for novel GSK-
3 binding proteins using yeast two-hybrid screening. We have identified AIP (Aurora-A 
Kinase Interacting Protein) as a protein that interacts with GSK-3. AIP has been 
reported to be a novel negative regulator of Aurora-A kinase where it might down-
regulates Aurora-A kinase through proteasome dependent degradation. Our study 
showed that AIP is able to bind both the homologous forms of GSK-3, GSK-3a and GSK-
3b in intact cells. This binding is not affected by SB216763, a specific GSK-3 inhibitor, 
indicating that the kinase activity of GSK-3 is not required for the interaction. AIP has 
the consensus motif –S-X-X-X-S- for substrate phosphorylation by GSK-3b and i 
sphosphorylated by GSK-3b in vitro. Our results suggest that AIPis a novel binding 
partner of GSK-3. 
 
